I think they're all suffering Arc fatigue...so much promise, yet so few results in the last 1-2 years. But I think they are now in a great position to grow substantially.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025